| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
VP, Therapeutic Dev. &CMO
1 company
Ando Dale G is a VP, Therapeutic Dev. &CMO at SANGAMO THERAPEUTICS, INC. Recent SEC Form 4 filings include 0 buys and 7 sells.
Estimated insider holdings value: $18K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 5, 2015 | SGMO Sangamo Therapeutics, Inc | VP, Therapeutic Dev. &CMO | Sale+OE | 15,000 | $12.29 | $184,393.50 | -13.4% | |
| May 5, 2015 | SGMO Sangamo Therapeutics, Inc | VP, Therapeutic Dev. &CMO | Sale+OE | 15,000 | $12.29 | $184,297.50 | -13.6% | |
| Apr 6, 2015 | SGMO Sangamo Therapeutics, Inc | VP, Therapeutic Dev. &CMO | Sale+OE | 15,000 | $14.94 | $224,172.00 | -13.6% | |
| Mar 5, 2015 | SGMO Sangamo Therapeutics, Inc | VP, Therapeutic Dev. &CMO | Sale+OE | 15,000 | $18.29 | $274,282.50 | -13.6% | |
| Feb 5, 2015 | SGMO Sangamo Therapeutics, Inc | VP, Therapeutic Dev. &CMO | Sale+OE | 15,000 | $12.93 | $193,950.00 | -13.6% | |
| Jan 5, 2015 | SGMO Sangamo Therapeutics, Inc | VP, Therapeutic Dev. &CMO | Sale+OE | 15,000 | $15.19 | $227,853.54 | -7.3% |